T 0546/98 du 20.10.1999

Identifiant européen de la jurisprudence: ECLI:EP:BA:1999:T054698.19991020
Date de la décision: 20 octobre 1999
Numéro de l'affaire: T 0546/98
Requête en révision de: -
Numéro de la demande: 86115473.0
Classe de la CIB: A61F 2/04
Langue de la procédure: Anglais
Distribution: Distribuées aux présidents des chambres de recours (C)
Téléchargement: Décision en anglais
Versions JO: Aucun lien JO trouvé
Autres décisions pour cet affaire: -
Résumés pour cette décision: -
Titre de la demande: Expandable intraluminal graft, and apparatus for implanting an expandable intraluminal graft
Nom du demandeur: Palmaz, Julio C.
Nom de l'opposant: Advanced Surgical Intervention, Inc.
Boston Scientific Corporation
Chambre: 3.2.02
Sommaire: -
Dispositions juridiques pertinentes: European Patent Convention Art 104(1) 1973 European Patent Convention Art 123(2) 1973 European Patent Convention Art 123(3) 1973 European Patent Convention Art 52(1) 1973 European Patent Convention Art 69(1) 1973 European Patent Convention Art 78(1) 1973 European Patent Convention Art 84 1973 European Patent Convention R 27(1) 1973 European Patent Convention R 29(1) 1973
Mots-clés: Inadmissibility of reconsidering patentability of the claims after appeal decision T 0818/93 ordering remittal to the first instance for adapting the description
Description properly adapted to amended claims
Apportionment of costs - refused
Referral to the Enlarged Board of Appeal - refused
Exergue: -
Affaires citées: G 0009/91 G 0010/91 G 0004/92 G 0001/93 T 0055/90 T 0757/91 T 0843/91 T 0113/92 T 1063/92 T 0167/93 T 0818/93
Affaires citantes: -

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance with the order to maintain the patent in amended form on the basis of the documents defined in the decision under appeal, provided that page 3a of the description is replaced by page 3a of the description submitted at the oral proceedings of 20 October 1999.

3. Both requests for apportionment of costs are rejected.